Kim Seroogy

Kim B. Seroogy

Vice Chair of Basic Research, Professor of Neurology, and Director of the Neuroscience Graduate Program

Medical Sciences Building

7209

COM Neurology Seroogy Lab - 0536

CARE/Crawley Building
3230 Eden Avenue, 7th Floor
Cincinnati, Ohio 45267-0536

Stetson Building
Suite 2300
Cincinnati, Ohio 45267-0525

Education

Bachelor's Degree, University of Wisconsin-Eau Claire 1979 (Biology (Zoology))

Doctoral Degree, University of California-Irvine 1986 (Biological Sciences)

Fellowship, Karolinska Institute, Department of Histology & Neurobiology 1987

Fellowship, University of North Carolina-Chapel Hill, Department of Physiology 1990

Research Support

Grant: #7-R01-NS-039128-04-A0-S0-E0 Investigators:Seroogy, Kim 04-01-2003 -03-31-2005 National Institute of Neurological Disorders and Stroke Neuregulins and Nigrostriatal System Function NS39128 Role:PI $268,625.00 Closed Level:Federal

Investigators:Seroogy, Kim 11-01-2003 -08-31-2006 Department of the Army Medical Research Acquisition Activity Neuregulins, Neuroprotections and Parkinson's Disease Role:PI $203,689.00 Closed Level:Federal

Investigators:Seroogy, Kim 10-01-2003 -09-27-2005 Department of the Army Medical Research and Materiel Command Neurotrophic Response to CNS Degeneration or Injury: Effects of Aging Role:PI $23,070.00 Closed Level:Federal

Grant: #SRS 003522 Investigators:Seroogy, Kim 01-01-2005 -09-30-2007 Michael J. Fox Foundation for Parkinson Neuregulin-2B: A Novel Trophic Factor for Midbrain Dopamine Neurons Role:PI $250,000.00 Completed

Grant: #3046851500-05-262 / R01 NS050311 Investigators:Seroogy, Kim 12-01-2004 -11-30-2010 National Institute of Neurological Disorders and Stroke Stem Cell Adaptability in Parkinson's Disease Role:PI $179,403.00 Completed Type:Grant

Grant: #SRS 005190 Investigators:Herman, James; Seroogy, Kim 07-01-2007 -09-30-2008 Davis Phinney Foundation Evaluation of Pre-Existing Chronic Stress-Induced Depression on Behavioral Dysfunction and Dopaminergic Neuronal Degeneration in the Injured-- Role:PI $50,000.00 Completed

Grant: #R01 NS060114 Investigators:Herman, James; Lipton, Jack; Seroogy, Kim 06-01-2008 -05-31-2013 National Institute of Neurological Disorders and Stroke Stress-Induced Depression and Parkinsonian Symptomology Role:PI $1,354,763.00 Active Level:Federal

Grant: #SRS 006006 Investigators:Herman, James; Seroogy, Kim 09-01-2008 -02-28-2010 Davis Phinney Foundation Effects of Exercise on Stress-Induced Dysfunction and Depression in a Model of Parkinson's Disease Role:PI $53,000.00 Completed Type:Grant

Grant: #3 R01 NS060114-02S1 Investigators:Seroogy, Kim 07-20-2009 -08-31-2010 National Institute of Neurological Disorders and Stroke Stress-Induced Depression and Parkinsonian Symptomology Role:PI $33,158.00 Active Level:Federal

Grant: #P50 NS058830 Investigators:Behbehani, Michael; Collier, Timothy; Herman, James; Lipton, Jack; Seroogy, Kim; Sortwell, Caryl; Steece-Collier, Kathy 09-30-2009 -07-31-2010 National Institute of Neurological Disorders and Stroke Aging and Parkinson's Disease: Models of Therapeutics and Neurologic Comorbidity Role:Collaborator $1,279,260.00 Active Level:Federal

Grant: #Acorda Contract Investigators:Seroogy, Kim 01-08-2010 -01-07-2012 Acorda Therapeutics, Inc. Acorda Sponsored Research Agreement Role:PI $40,000.00 Active Level:Industry

Grant: #SRS 007011 Investigators:Seroogy, Kim 07-01-2010 -06-30-2012 University of Cincinnati Neuroscience Institute Growth Factor Therapy and Parkinson's Disease: Neurorestoration in Aging Animals Role:PI $30,000.00 Active Level:Industry

Grant: #61-0095UC / P50-NS058830 Investigators:Herman, James; Seroogy, Kim 08-01-2010 -07-31-2014 National Institute of Neurological Disorders and Stroke Project 4: Glucocorticoid Mechanisms of Stress-Induced Depression and Parkinsonian Symptomology Role:PI $185,708.00 Active Level:Federal

Grant: #SRS 007509 Investigators:Seroogy, Kim 05-19-2011 -05-18-2012 Acorda Therapeutics, Inc. Acorda Sponsored Research Agreement Role:PI $50,000.00 Active

Grant: #11-272-RH-03CRD Investigators:Herman, James; Seroogy, Kim 09-29-2011 -09-29-2014 Air Force Research Laboratory Effects of Stress on Performance Role:Collaborator $1.00 Awarded Level:Federal

Grant: #T32NS007453 Investigators:Herman, James; Seroogy, Kim 07-01-2016 -06-30-2021 National Institute of Neurological Disorders and Stroke Predoctoral Training Program in the Neurosciences Role:Collaborator $153,282.00 Active Level:Federal

Grant: #R01 NS100469 Investigators:Baccei, Mark; Berta, Temugin; Seroogy, Kim 06-01-2017 -05-30-2019 National Institute of Neurological Disorders and Stroke Identification of novel analgesic targets in ascending spinal projection neurons Role:Collaborator $199,062.00 Awarded Level:Federal

Grant: #16661 Investigators:Diao, Jiajie; Seroogy, Kim 11-01-2018 -04-30-2020 Michael J. Fox Foundation for Parkinson's Research Chaperones of alpha-synuclein for membrane fusion involved in synaptic transmission Role:Collaborator $99,081.00 Awarded Level:Private Non-Profit

Grant: #305961 / 16452 Investigators:Espay, Alberto; Seroogy, Kim 01-23-2019 -01-22-2021 Michael J. Fox Foundation for Parkinson's Research GBA1 defects cause a C5a-C5aR1-induced neurodegeneration in Parkinson's disease Role:PI $30,958.00 Awarded Level:Private Non-Profit

Publications

Peer Reviewed Publications

Suidan, Georgette L; Dickerson, Jonathan W; Chen, Yi; McDole, Jeremiah R; Tripathi, Pulak; Pirko, Istvan; Seroogy, Kim B; Johnson, Aaron J (2010. )CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions.Journal of immunology (Baltimore, Md. : 1950), ,184 (2 ),1031-40

Dickerson, J W; Hemmerle, A M; Numan, S; Lundgren, K H; Seroogy, K B (2009. )Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats.Neuroscience, ,163 (1 ),482-9

Yurek, David M; Fletcher, Anita M; Smith, George M; Seroogy, Kim B; Ziady, Assem G; Molter, Joseph; Kowalczyk, Tomasz H; Padegimas, Linas; Cooper, Mark J (2009. )Long-term transgene expression in the central nervous system using DNA nanoparticles.Molecular therapy : the journal of the American Society of Gene Therapy, ,17 (4 ),641-50

Cass, Wayne A; Peters, Laura E; Harned, Michael E; Seroogy, Kim B (2006. )Protection by GDNF and other trophic factors against the dopamine-depleting effects of neurotoxic doses of methamphetamine.Annals of the New York Academy of Sciences, ,1074 ,272-81

Numan, Suzanne; Gall, Christine M; Seroogy, Kim B (2005. )Developmental expression of neurotrophins and their receptors in postnatal rat ventral midbrain.Journal of molecular neuroscience : MN, ,27 (2 ),245-60

Zhang, Lixin; Fletcher-Turner, Anita; Marchionni, Mark A; Apparsundaram, Subbu; Lundgren, Kerstin H; Yurek, David M; Seroogy, Kim B (2004. )Neurotrophic and neuroprotective effects of the neuregulin glial growth factor-2 on dopaminergic neurons in rat primary midbrain cultures.Journal of neurochemistry, ,91 (6 ),1358-68

Yurek, David M; Zhang, Lixin; Fletcher-Turner, Anita; Seroogy, Kim B (2004. )Supranigral injection of neuregulin1-beta induces striatal dopamine overflow.Brain research, ,1028 (1 ),116-9

Dimayuga, Filomena O; Ding, Qunxing; Keller, Jeffrey N; Marchionni, Mark A; Seroogy, Kim B; Bruce-Keller, Annadora J (2003. )The neuregulin GGF2 attenuates free radical release from activated microglial cells. Journal of neuroimmunology, ,136 (1-2 ),67-74

Bruce, Laura L; Kornblum, Harley I; Seroogy, Kim B Comparison of thalamic populations in mammals and birds: expression of ErbB4 mRNA. Brain research bulletin, ,57 (3-4 ),455-61

Lee, Jaewon; Seroogy, Kim B; Mattson, Mark P (2002. )Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice. Journal of neurochemistry, ,80 (3 ),539-47

Hicks, R R; Zhang, L; Atkinson, A; Stevenon, M; Veneracion, M; Seroogy, K B (2002. )Environmental enrichment attenuates cognitive deficits, but does not alter neurotrophin gene expression in the hippocampus following lateral fluid percussion brain injury. Neuroscience, ,112 (3 ),631-7

Yurek, D M; Seroogy, K B (2000. )Differential expression of neurotrophin and neurotrophin receptor mRNAs in and adjacent to fetal midbrain grafts implanted into the dopamine-denervated striatum. The Journal of comparative neurology, ,423 (3 ),462-73

Zhang, L; Dhillon, H S; Barron, S; Hicks1, R R; Prasad, R M; Seroogy, K B (2000. )Effects of chronic ethanol administration on expression of BDNF and trkB mRNAs in rat hippocampus after experimental brain injury. Brain research. Molecular brain research, ,79 (1-2 ),174-9

Kornblum, H I; Yanni, D S; Easterday, M C; Seroogy, K B (2000. )Expression of the EGF receptor family members ErbB2, ErbB3, and ErbB4 in germinal zones of the developing brain and in neurosphere cultures containing CNS stem cells. Developmental neuroscience, ,22 (1-2 ),16-24

Hicks, R R; Martin, V B; Zhang, L; Seroogy, K B (1999. )Mild experimental brain injury differentially alters the expression of neurotrophin and neurotrophin receptor mRNAs in the hippocampus.Experimental neurology, ,160 (2 ),469-78

Noble, F; Wank, S A; Crawley, J N; Bradwejn, J; Seroogy, K B; Hamon, M; Roques, B P (1999. )International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacological reviews, ,51 (4 ),745-81

Kornblum, H I; Zurcher, S D; Werb, Z; Derynck, R; Seroogy, K B (1999. )Multiple trophic actions of heparin-binding epidermal growth factor (HB-EGF) in the central nervous system. The European journal of neuroscience, ,11 (9 ),3236-46

Hicks, R R; Li, C; Zhang, L; Dhillon, H S; Prasad, M R; Seroogy, K B (1999. )Alterations in BDNF and trkB mRNA levels in the cerebral cortex following experimental brain trauma in rats. Journal of neurotrauma, ,16 (6 ),501-10

Numan, S; Seroogy, K B (1999. )Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. The Journal of comparative neurology, ,403 (3 ),295-308

Opanashuk, L A; Mark, R J; Porter, J; Damm, D; Mattson, M P; Seroogy, K B (1999. )Heparin-binding epidermal growth factor-like growth factor in hippocampus: modulation of expression by seizures and anti-excitotoxic action. The Journal of neuroscience : the official journal of the Society for Neuroscience, ,19 (1 ),133-46

Numan, S; Lane-Ladd, S B; Zhang, L; Lundgren, K H; Russell, D S; Seroogy, K B; Nestler, E J (1998. )Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal. The Journal of neuroscience : the official journal of the Society for Neuroscience, ,18 (24 ),10700-8

Hicks, R R; Zhang, L; Dhillon, H S; Prasad, M R; Seroogy, K B (1998. )Expression of trkB mRNA is altered in rat hippocampus after experimental brain trauma. Brain research. Molecular brain research, ,59 (2 ),264-8

Hicks, Ramona R.; Boggs, Arden; Leider, Denise; Kraemer, Philip; Brown, Russell; Scheff, Stephen W.; Seroogy, Kim B. (1998. )Effects of Exercise Following Lateral Fluid Percussion Brain Injury in Rats. Restorative neurology and neuroscience, ,12 (1 ),41-47

Hicks, R R; Numan, S; Dhillon, H S; Prasad, M R; Seroogy, K B (1997. )Alterations in BDNF and NT-3 mRNAs in rat hippocampus after experimental brain trauma. Brain research. Molecular brain research, ,48 (2 ),401-6

Kornblum, H I; Hussain, R J; Bronstein, J M; Gall, C M; Lee, D C; Seroogy, K B (1997. )Prenatal ontogeny of the epidermal growth factor receptor and its ligand, transforming growth factor alpha, in the rat brain. The Journal of comparative neurology, ,380 (2 ),243-61

Numan, S; Seroogy, K B (1997. )Increased expression of trkB mRNA in rat caudate--putamen following 6-OHDA lesions of the nigrostriatal pathway. The European journal of neuroscience, ,9 (3 ),489-95

Berkowitz, E A; Seroogy, K B; Schroeder, J A; Russell, W E; Evans, E P; Riedel, R F; Phillips, H K; Harrison, C A; Lee, D C; Luetteke, N C (1996. )Characterization of the mouse transforming growth factor alpha gene: its expression during eyelid development and in waved 1 tissues. Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, ,7 (9 ),1271-82

Kornblum, H I; Gall, C M; Seroogy, K B; Lauterborn, J C (1995. )A subpopulation of striatal gabaergic neurons expresses the epidermal growth factor receptor. Neuroscience, ,69 (4 ),1025-1029

Numan, S; Lundgren, K H; Wright, D E; Herman, J P; Seroogy, K B (1995. )Increased expression of 5HT2 receptor mRNA in rat striatum following 6-OHDA lesions of the adult nigrostriatal pathway. Brain research. Molecular brain research, ,29 (2 ),391-6

Seroogy, K B; Gall, C M; Lee, D C; Kornblum, H I (1995. )Proliferative zones of postnatal rat brain express epidermal growth factor receptor mRNA. Brain research, ,670 (1 ),157-64

Wright, D E; Seroogy, K B; Lundgren, K H; Davis, B M; Jennes, L (1995. )Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain.The Journal of comparative neurology, ,351 (3 ),357-73

Seroogy, K B; Numan, S; Gall, C M; Lee, D C; Kornblum, H I (1994. )Expression of EGF receptor mRNA in rat nigrostriatal system. Neuroreport, ,6 (1 ),105-8

Davis, B M; Albers, K M; Seroogy, K B; Katz, D M (1994. )Overexpression of nerve growth factor in transgenic mice induces novel sympathetic projections to primary sensory neurons.The Journal of comparative neurology, ,349 (3 ),464-74

Seroogy, K B; Lundgren, K H; Tran, T M; Guthrie, K M; Isackson, P J; Gall, C M (1994. )Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.The Journal of comparative neurology, ,342 (3 ),321-34

Seroogy, K B; Gall, C M (1993. )Expression of neurotrophins by midbrain dopaminergic neurons.Experimental neurology, ,124 (1 ),119-28

Seroogy, K B; Lundgren, K H; Lee, D C; Guthrie, K M; Gall, C M (1993. )Cellular localization of transforming growth factor-alpha mRNA in rat forebrain. Journal of neurochemistry, ,60 (5 ),1777-82

Ceccatelli, S; Seroogy, K B; Millhorn, D E; Terenius, L (1992. )Presence of a dynorphin-like peptide in a restricted subpopulation of catecholaminergic neurons in rat nucleus tractus solitarii. Brain research, ,589 (2 ),225-30

Gall, C M; Gold, S J; Isackson, P J; Seroogy, K B (1992. )Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons. Molecular and cellular neurosciences, ,3 (1 ),56-63

Fallon, J H; Di Salvo, J; Loughlin, S E; Gimenez-Gallego, G; Seroogy, K B; Bradshaw, R A; Morrison, R S; Ciofi, P; Thomas, K A (1992. )Localization of acidic fibroblast growth factor within the mouse brain using biochemical and immunocytochemical techniques. Growth factors (Chur, Switzerland), ,6 (2 ),139-57

Seroogy, K B; Bayliss, D A; Szymeczek, C L; Hökfelt, T; Millhorn, D E (1991. )Transient expression of somatostatin messenger RNA and peptide in the hypoglossal nucleus of the neonatal rat. Brain research. Developmental brain research, ,60 (2 ),241-52

Bayliss, D A; Seroogy, K B; Millhorn, D E (1991. )Distribution and regulation by estrogen of progesterone receptor in the hypothalamus of the cat. Endocrinology, ,128 (5 ),2610-7

Seroogy, K B; Han, V K; Lee, D C (1991. )Regional expression of transforming growth factor-alpha mRNA in the rat central nervous system. Neuroscience letters, ,125 (2 ),241-5

Czyzyk-Krzeska, M F; Bayliss, D A; Seroogy, K B; Millhorn, D E (1991. )Gene expression for peptides in neurons of the petrosal and nodose ganglia in rat. Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale, ,83 (2 ),411-8

Seroogy, K B; Mohapatra, N K; Lund, P K; Réthelyi, M; McGehee, D S; Perl, E R (1990. )Species-specific expression of cholecystokinin messenger RNA in rodent dorsal root ganglia. Brain research. Molecular brain research, ,7 (2 ),171-6

Seroogy, K B; Fallon, J H (1989. )Forebrain projections from cholecystokininlike-immunoreactive neurons in the rat midbrain.The Journal of comparative neurology, ,279 (3 ),415-35

Seroogy, K B; Dangaran, K; Lim, S; Haycock, J W; Fallon, J H (1989. )Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions.The Journal of comparative neurology, ,279 (3 ),397-414

Gall, C M; Hendry, S H; Seroogy, K B; Jones, E G; Haycock, J W (1987. )Evidence for coexistence of GABA and dopamine in neurons of the rat olfactory bulb.The Journal of comparative neurology, ,266 (3 ),307-18

Hunt, C A; Seroogy, K B; Gall, C M; Jones, E G (1987. )Cholecystokinin innervation of rat thalamus, including fibers to ventroposterolateral nucleus from dorsal column nuclei. Brain research, ,426 (2 ),257-69

Code, R A; Seroogy, K B; Fallon, J H (1987. )Some transforming growth factor-alpha connections and their colocalization with enkephalin in the rat central nervous system. Brain research, ,421 (1-2 ),401-5

Seroogy, K B; Mehta, A; Fallon, J H (1987. )Neurotensin and cholecystokinin coexistence within neurons of the ventral mesencephalon: projections to forebrain. Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale, ,68 (2 ),277-89

Ribak, C E; Seress, L; Peterson, G M; Seroogy, K B; Fallon, J H; Schmued, L C (1986. )A GABAergic inhibitory component within the hippocampal commissural pathway. The Journal of neuroscience : the official journal of the Society for Neuroscience, ,6 (12 ),3492-8

Gall, C; Seroogy, K B; Brecha, N (1986. )Distribution of VIP- and NPY-like immunoreactivities in rat main olfactory bulb. Brain research, ,374 (2 ),389-94

Seroogy, K B; Brecha, N; Gall, C (1985. )Distribution of cholecystokinin-like immunoreactivity in the rat main olfactory bulb.The Journal of comparative neurology, ,239 (4 ),373-83

Fallon, J H; Seroogy, K B (1985. )The distribution and some connections of cholecystokinin neurons in the rat brain. Annals of the New York Academy of Sciences, ,448 ,121-32

Seroogy, K B; Fallon, J H; Loughlin, S E; Leslie, F M (1985. )Few cortical cholecystokinin immunoreactive neurons have long projections. Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale, ,59 (3 ),533-42

Fallon, J H; Seroogy, K B; Loughlin, S E; Morrison, R S; Bradshaw, R A; Knaver, D J; Cunningham, D D (1984. )Epidermal growth factor immunoreactive material in the central nervous system: location and development. Science (New York, N.Y.), ,224 (4653 ),1107-9

Fallon, J H; Seroogy, K B (1984. )Visual and auditory pathways contain cholecystokinin: evidence from immunofluorescence and retrograde tracing. Neuroscience letters, ,45 (1 ),81-7

Seroogy, K B; Seress, L; Ribak, C E (1983. )Ultrastructure of commissural neurons of the hilar region in the hippocampal dentate gyrus. Experimental neurology, ,82 (3 ),594-608

Ruiz-Argüelles, A; Seroogy, K B; Ritts, R E (1982. )In vitro effect of cimetidine on human cell-mediated cytotoxicity. I. Inhibition of natural killer cell activity. Cellular immunology, ,69 (1 ),1-12

Noble,F., Wank,S. A., Crawley,J. N., Bradwejn,J., Seroogy,K. B., Hamon,M., Roques,B. P. (1999. )International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors .Pharmacological reviews, ,51 (4 ),745 -781

Hemmerle, Ann M; Dickerson, Jonathan W; Herring, Nicole R; Schaefer, Tori L; Vorhees, Charles V; Williams, Michael T; Seroogy, Kim B (2012. )(±)3,4-methylenedioxymethamphetamine ("Ecstacy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain.The Journal of comparative neurology, ,

Hemmerle, Ann M; Herman, James P; Seroogy, Kim B (2012. )Stress, depression and Parkinson's disease.Experimental neurology, ,233 (1 ),79-86

Brumovsky, Pablo R; Robinson, David R; La, Jun-Ho; Seroogy, Kim B; Lundgren, Kerstin H; Albers, Kathryn M; Kiyatkin, Michael E; Seal, Rebecca P; Edwards, Robert H; Watanabe, Masahiko; Hökfelt, Tomas; Gebhart, G F (2011. )Expression of vesicular glutamate transporters type 1 and 2 in sensory and autonomic neurons innervating the mouse colorectum.The Journal of comparative neurology, ,519 (16 ),3346-66

Brumovsky, Pablo R; Seroogy, Kim B; Lundgren, Kerstin H; Watanabe, Masahiko; Hökfelt, Tomas; Gebhart, G F (2011. )Some lumbar sympathetic neurons develop a glutamatergic phenotype after peripheral axotomy with a note on VGLUT?-positive perineuronal baskets.Experimental neurology, ,230 (2 ),258-72

Braun, A A; Herring, N R; Schaefer, T L; Hemmerle, A M; Dickerson, J W; Seroogy, K B; Vorhees, C V; Williams, M T (2011. )Neurotoxic (+)-methamphetamine treatment in rats increases brain-derived neurotrophic factor and tropomyosin receptor kinase B expression in multiple brain regions.Neuroscience, ,184 ,164-71

McKlveen, Jessica M; Myers, Brent; Flak, Jonathan N; Bundzikova, Jana; Solomon, Matia B; Seroogy, Kim B; Herman, James P (2013. )Role of prefrontal cortex glucocorticoid receptors in stress and emotion.Biological psychiatry, ,74 (9 ),672-9

Hemmerle, A M; Dickerson, J W; Herman, J P; Seroogy, K B (2013. )Stress exacerbates experimental Parkinson's disease.Molecular psychiatry, ,

Brumovsky, Pablo R; Seal, Rebecca P; Lundgren, Kerstin H; Seroogy, Kim B; Watanabe, Masahiko; Gebhart, G F (2013. )Expression of vesicular glutamate transporters in sensory and autonomic neurons innervating the mouse bladder.The Journal of urology, ,189 (6 ),2342-9

Malet, M; Vieytes, C A; Lundgren, K H; Seal, R P; Tomasella, E; Seroogy, K B; Hökfelt, T; Gebhart, G F; Brumovsky, P R (2013. )Transcript expression of vesicular glutamate transporters in lumbar dorsal root ganglia and the spinal cord of mice - Effects of peripheral axotomy or hindpaw inflammation.Neuroscience, ,248C ,95-111

Suidan, Georgette L; Dickerson, Jonathan W; Johnson, Holly L; Chan, Theresa W; Pavelko, Kevin D; Pirko, Istvan; Seroogy, Kim B; Johnson, Aaron J (2012. )Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability.Journal of neuroinflammation, ,9 ,218

Honors and Awards

2007 President, Ohio Miami Valley Chapter, Society for Neuroscience

2000 -2002 Wethington Research Excellence Awards, University of Kentucky Status:Recipient

1997 -1999 NARSAD Independent Investigator Award Status:Recipient

1993 -1995 American Parkinson's Disease Association Research Award Status:Recipient

1991 -1994 Scottish Rite Schizophrenia Research Foundation Award Status:Recipient

1991 -1994 National Parkinson Foundation Research Awards (3) Status:Recipient

1991 American-Scandinavian Foundation Fellow Award Status:Recipient

1988 -1990 NIH Individual Postdoctoral Fellowship, UNC-Chapel Hill Status:Recipient

1987 -1988 NIH Postdoctoral Training Fellowship, UNC-Chapel HIll Status:Recipient Type:Fellowship

1986 -1987 NATO Postdoctoral Fellowship in Science, Karolinska Institute, Sweden Status:Recipient Type:Fellowship

1983 -1986 NIMH Individual Predoctoral Fellowship, UC Irvine Status:Recipient Type:Fellowship

Positions and Work Experience

1990 -2003 Assistant, Associate and Full Professor, Dept of Anatomy & Neurobiology, University of Kentucky College of Medicine, Lexington, KY

2003 -To Present Director, The Selma Schottenstein Harris Laboratory for Research in Parkinson's, University of Cincinnati College of Medicine, Cincinnati, OH

2003 -To Present Professor, Department of Neurology, University of Cincinnati College of Medicine, Cincinnati, OH

2004 - Visiting Scientist, Department of Neuroscience, Karolinska Institute, Stockholm, Sweden

2006 -To Present Vice-Chair for Basic Research, Department of Neurology, University of Cincinnati College of Medicine, Cincinnati, OH

Post Graduate Training and Education

1986-1987 Postdoctoral Fellow, Dept of Histology & Neurobiology, Karolinska Institute , ,Stockholm, Sweden

1987-1990 Postdoctoral Fellow, Dept of Physiology, University of North Carolina, ,Chapel Hill, NC

Keywords

Parkinson's disease

Research and Practice Interests

Growth factor therapy in models of Parkinson's disease. Chronic stress-induced depression and Parkinson's disease. Organization, plasticity and neuroprotective roles of neurotrophic factors, particularly neuregulins and neurotrophins, in the normal and injured dopaminergic mesostriatal system. Modulation of trophic factor expression after stress, drugs of abuse, prenatal immune activation and blood-brain-barrier disruption.

Contact Information

Research - CARE/Crawley Building
3230 Eden Avenue, 7th Floor
Cincinnati  Ohio, 45267-0536
Phone: 513-558-7086
Fax: 513-558-7009
kim.seroogy@uc.edu

Academic - Stetson Building
Suite 2300
Cincinnati  Ohio, 45267-0525
Phone: 513-558-2968
Fax: 513-558-4887
kim.seroogy@uc.edu